Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary Cutaneous Small Vessel Vasculitis.

James P. Russell1, Roger H. Weenig

  • 1Department of Dermatology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Weenig.roger@mayo.edu

Current Treatment Options in Cardiovascular Medicine
|April 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Primary cutaneous vasculitis management focuses on symptomatic relief for mild cases and potent immunosuppression for severe disease. Current evidence does not support new biological therapies.

Area of Science:

  • Dermatology
  • Rheumatology
  • Immunology

Background:

  • Cutaneous vasculitis encompasses various disorders, with primary forms including leukocytoclastic vasculitis, essential mixed cryoglobulinemia, urticarial vasculitis, Henoch-Schönlein purpura, and erythema elevatum diutinum.
  • Management strategies for these conditions are based on limited evidence.

Purpose of the Study:

  • To establish a consensus opinion on the management of primary cutaneous vasculitis.
  • To guide therapeutic decisions based on disease severity and symptoms.

Main Methods:

  • Review of existing literature and clinical data.
  • Development of a consensus-based approach to treatment.

Main Results:

  • Conservative treatment (leg elevation, antihistamines, NSAIDs) is recommended for symptomatic relief.

Related Experiment Videos

  • Mild recurrent disease may be treated with colchicine, dapsone, or prednisone.
  • Severe or systemic disease requires potent immunosuppressants like prednisone, azathioprine, or mycophenolate mofetil.
  • Plasmapheresis and IVIg are options for refractory cases.
  • Insufficient evidence exists for biological or monoclonal antibody therapies.

    • Conclusions:

    • Treatment should be tailored to symptomatic or systemic involvement.
    • A stepwise approach from conservative measures to potent immunosuppression is advised.
    • Further research is needed to evaluate novel therapeutic agents.